Lantheus Holdings SG&A Expense (Semi Annual) Trends

Lantheus Holdings, Inc. (LNTH)

76.10 +0.40 (+0.53%) USD | NASDAQ | Apr 02, 16:00

76.15 +0.05 (+0.07%) After-Hours: 20:00

View SG&A Expense (Semi Annual) for LNTH.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (Semi Annual) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (Semi Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (Semi Annual) Benchmarks

Start Trial

Anika Therapeutics, Inc.	--
BioCryst Pharmaceuticals, Inc.	--
Iovance Biotherapeutics, Inc.	--
Plus Therapeutics, Inc.	--
BioStem Technologies, Inc.	--